Lualba Tablet 10 mg (Leflunomide)

Adult dose

Administer a loading dose of 100 mg once daily for 3 days. For patients with rheumatoid arthritis, administer a maintenance dose of 20 mg once daily. Some patients experienced adverse reactions such as alopecia, weight loss, and increased liver enzyme levels when treated with 25 mg once daily. Therefore, the maintenance dose should not exceed 20 mg once daily. If the patient's clinical tolerability is poor, the maintenance dose may be reduced to 10 mg once daily. For patients with psoriatic arthritis, administer a maintenance dose of 20 mg once daily.

This medication is slowly eliminated from the body, so side effects may appear or persist even after discontinuation. If serious adverse reactions occur, a special medication may need to be used to rapidly eliminate this drug from the body. It can affect liver function, so patients with liver disease or impaired liver function should be particularly cautious when using this drug. Regular liver function tests should be conducted for a certain period before and after administration, and if liver enzymes significantly increase, the dose may need to be reduced or stopped. There may be an increased risk of liver toxicity when used with other specific medications, so consultation with a physician is necessary. Patients with a history of lung disease or pneumonia symptoms require careful evaluation and examination by a doctor before using this drug. This medication can suppress immune function, so if a serious infection occurs, treatment should be stopped and appropriate care should be received. Severe allergic reactions or ulcers may occur, so any unusual symptoms should be reported to healthcare professionals promptly. The administration of this drug may be temporarily suspended before and after surgery as it can affect wound healing. There may be an increased risk of developing malignancies during long-term use, so caution is required. Treatment should be conducted under the supervision of a physician experienced in treating rheumatic diseases, and if any unusual symptoms occur, immediate consultation with a doctor is necessary. Women who are pregnant or may become pregnant should not take this drug, and if pregnancy is confirmed while taking this medication, they should consult a physician immediately. Patients with hereditary lactose intolerance should also not take this drug. Interstitial pneumonia, blood disorders, liver disease, kidney disorders, severe infections, or immunocompromised patients should use this medication cautiously. Safety in children has not been established, and it is not recommended for patients under 18 years of age. In case of overdose, symptoms such as diarrhea, abdominal pain, or liver function abnormalities may occur, and drug removal treatment may be necessary. This drug may interact with other medications, so healthcare providers should be informed of any other medications being taken. Regular blood pressure and blood tests should be conducted while taking this medication, and immediate treatment should be sought if symptoms of infection appear. Nursing women should not take this medication.

• Diarrhea
• elevation of liver enzymes (ALT, AST)
• hair loss
• rash
• weakness
• flu-like syndrome
• upper respiratory infection
• injury
• pain
• abdominal pain

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. It is also important to store it in a sealed container to avoid contact with air. The storage temperature should be kept cool, below 25 degrees Celsius, to maintain the effectiveness of the medication.

Appearance

White to almost white round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle